ResMed holder plans sale of 4,991 common shares

ResMed shareholder Michael Farrell lists a proposed sale of 4,991 shares of common stock, to be sold for cash on 08/07/2026 through Fidelity Brokerage Services LLC on the NYSE, in connection with a stock option exercise.

Accepted by SEC EDGAR 08/07/2026 - 10:58 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

ResMed shareholder Michael Farrell lists a proposed sale of 4,991 shares of common stock, to be sold for cash on 08/07/2026 through Fidelity Brokerage Services LLC on the NYSE, in connection with a stock option exercise.

The disclosure also lists prior sales of 4,991 shares of common stock on each of 05/07/2026, 06/08/2026, and 07/07/2026, with aggregate sale prices of $1,037,232.61, $968,064.34, and $1,090,770.57, respectively.

Key Figures

Shares to be sold: 4,991 shares Planned sale date: 08/07/2026 Prior sale 1 amount: $1,037,232.61 +3 more

6 metrics

Shares to be sold 4,991 shares Common stock listed as securities to be sold on 08/07/2026

Planned sale date 08/07/2026 Date for sale of 4,991 shares of common stock

Prior sale 1 amount $1,037,232.61 Aggregate amount for 4,991 shares sold on 05/07/2026

Prior sale 2 amount $968,064.34 Aggregate amount for 4,991 shares sold on 06/08/2026

Prior sale 3 amount $1,090,770.57 Aggregate amount for 4,991 shares sold on 07/07/2026

Shares sold past 3 months 14,973 shares 4,991 shares sold on each of three dates in May, June, and July 2026

Key Terms

Stock Option Exercise, Securities To Be Sold, Securities Sold During The Past 3 Months

3 terms

Stock Option Exercise financial

"Common | 08/07/2026 | Stock Option Exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Securities To Be Sold financial

"144: Securities To Be Sold Common | 08/07/2026"

Securities Sold During The Past 3 Months financial

"144: Securities Sold During The Past 3 Months Michael Farrell"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does ResMed (RMD) shareholder Michael Farrell plan to sell under this Form 144?

Michael Farrell plans to sell 4,991 shares of ResMed common stock for cash on 08/07/2026. The shares are associated with a stock option exercise and are to be sold through Fidelity Brokerage Services LLC on the NYSE.

On what date are the new ResMed (RMD) shares expected to be sold?

The planned sale date for the 4,991 shares of ResMed common stock is 08/07/2026. The transaction is tied to a stock option exercise and is designated as a cash sale on the NYSE via Fidelity Brokerage Services LLC.

Which broker is handling the proposed ResMed (RMD) share sale for Michael Farrell?

The proposed sale of 4,991 ResMed shares is listed through Fidelity Brokerage Services LLC, located in Smithfield, Rhode Island. The shares are to be sold for cash on the NYSE in connection with a stock option exercise dated 08/07/2026.

What prior ResMed (RMD) stock sales did Michael Farrell report in the last three months?

Michael Farrell reported selling 4,991 shares of ResMed common stock on 05/07/2026, 06/08/2026, and 07/07/2026, for aggregate amounts of $1,037,232.61, $968,064.34, and $1,090,770.57, respectively, over the past three months.

How many ResMed (RMD) shares has Michael Farrell sold recently in total according to this Form 144?

Over the past three months, Michael Farrell has sold 4,991 shares on each of three dates, totaling 14,973 shares. The aggregate sale proceeds listed are $1,037,232.61, $968,064.34, and $1,090,770.57 for those respective transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001485164
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	RESMED INC
SEC File Number	001-15317
Address of Issuer	9001 SPECTRUM CENTER BLVD. SAN DIEGO CALIFORNIA 92123
Phone	8587462400
Name of Person for Whose Account the Securities are To Be Sold	Farrell Michael J.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	4991	1026596.27	145056384	08/07/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/07/2026	Stock Option Exercise	Issuer			4991	08/07/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Michael Farrell 9001 Spectrum Center Blvd. San Diego CA 92123	Common	05/07/2026	4991	1037232.61
Michael Farrell 9001 Spectrum Center Blvd. San Diego CA 92123	Common	06/08/2026	4991	968064.34
Michael Farrell 9001 Spectrum Center Blvd. San Diego CA 92123	Common	07/07/2026	4991	1090770.57

144: Remarks and Signature

Remarks
Date of Notice	08/07/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	10/31/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gary Redman, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Michael Farrell
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)